Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol. 1983;14(4):471–9.
Article
CAS
PubMed
Google Scholar
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23(2):185–8.
Article
CAS
PubMed
Google Scholar
Kriaucionis S, Bird A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 2004;32(5):1818–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olson CO, Zachariah RM, Ezeonwuka CD, Liyanage VR, Rastegar M. Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS ONE. 2014;9(3):e90645.
Article
PubMed
PubMed Central
Google Scholar
Krishnaraj R, Ho G, Christodoulou J. RettBASE: Rett syndrome database update. Hum Mutat. 2017;38(8):922–31.
Article
PubMed
Google Scholar
Fagiolini M, Patrizi A, LeBlanc J, Jin LW, Maezawa I, Sinnett S, et al. Intellectual and developmental disabilities research centers: a multidisciplinary approach to understand the pathogenesis of methyl-CpG binding protein 2-related disorders. Neuroscience. 2020;445:190–206.
Article
CAS
PubMed
Google Scholar
Tillotson R, Bird A. The molecular basis of MeCP2 function in the brain. J Mol Biol. 2019.
Kozinetz CA, Skender ML, MacNaughton N, Almes MJ, Schultz RJ, Percy AK, et al. Epidemiology of Rett syndrome: a population-based registry. Pediatrics. 1993;91(2):445–50.
Article
CAS
PubMed
Google Scholar
Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, et al. Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 2006;148(3):347–52.
Article
PubMed
Google Scholar
Anderson A, Wong K, Jacoby P, Downs J, Leonard H. Twenty years of surveillance in Rett syndrome: what does this tell us? Orphanet J Rare Dis. 2014;9:87.
Article
PubMed
PubMed Central
Google Scholar
Tarquinio DC, Hou W, Neul JL, Kaufmann WE, Glaze DG, Motil KJ, et al. The changing face of survival in Rett syndrome and MECP2-related disorders. Pediatr Neurol. 2015;53(5):402–11.
Article
PubMed
PubMed Central
Google Scholar
Hagberg BA, Skjeldal OH. Rett variants: a suggested model for inclusion criteria. Pediatr Neurol. 1994;11(1):5–11.
Article
CAS
PubMed
Google Scholar
Leonard H, Cobb S, Downs J. Clinical and biological progress over 50 years in Rett syndrome. Nat Rev Neurol. 2017;13(1):37–51.
Article
CAS
PubMed
Google Scholar
Bebbington A, Anderson A, Ravine D, Fyfe S, Pineda M, de Klerk N, et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology. 2008;70(11):868–75.
Article
CAS
PubMed
Google Scholar
Cuddapah VA, Pillai RB, Shekar KV, Lane JB, Motil KJ, Skinner SA, et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet. 2014;51(3):152–8.
Article
CAS
PubMed
Google Scholar
Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, et al. Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome. Neurology. 2008;70(16):1313–21.
Article
CAS
PubMed
Google Scholar
Katz DM, Bird A, Coenraads M, Gray SJ, Menon DU, Philpot BD, et al. Rett syndrome: crossing the threshold to clinical translation. Trends Neurosci. 2016;39(2):100–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gomathi M, Padmapriya S, Balachandar V. Drug studies on Rett syndrome: from bench to bedside. J Autism Dev Disord. 2020;50(8):2740–64.
Article
PubMed
Google Scholar
Fu C, Armstrong D, Marsh E, Lieberman D, Motil K, Witt R, et al. Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatr Open. 2020;4(1):e000717.
Article
PubMed
PubMed Central
Google Scholar
Fu C, Armstrong D, Marsh E, Lieberman D, Motil K, Witt R, et al. Multisystem comorbidities in classic Rett syndrome: a scoping review. BMJ Paediatr Open. 2020;4(1):e000731.
Article
PubMed
PubMed Central
Google Scholar
Leonard H, Ravikumar M, Baikie G, Naseem N, Ellaway C, Percy A, et al. Assessment and management of nutrition and growth in Rett syndrome. J Pediatr Gastroenterol Nutr. 2013;57(4):451–60.
Article
PubMed
PubMed Central
Google Scholar
Tarquinio DC, Motil KJ, Hou W, Lee H-S, Glaze DG, Skinner SA, et al. Growth failure and outcome in Rett syndrome specific growth references. Neurology. 2012;79(16):1653–61.
Article
PubMed
PubMed Central
Google Scholar
Downs J, Wong K, Ravikumara M, Ellaway C, Elliott EJ, Christodoulou J, et al. Experience of gastrostomy using a quality care framework: the example of rett syndrome. Medicine. 2014;93(28):328.
Article
Google Scholar
Wong K, Downs J, Ellaway C, Baikie G, Ravikumara M, Jacoby P, et al. Impact of gastrostomy placement on nutritional status, physical health, and parental well-being of females with Rett syndrome: a longitudinal study of an australian population. J Pediatr. 2018;200:188-95e1.
Article
PubMed
Google Scholar
Cutri-French C, Armstrong D, Saby J, Gorman C, Lane J, Fu C, et al. Comparison of core features in four developmental encephalopathies in the Rett natural history study. Ann Neurol. 2020;88(2):396–406.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jian L, Nagarajan L, de Klerk N, Ravine D, Bower C, Anderson A, et al. Predictors of seizure onset in Rett syndrome. J Pediatr. 2006;149(4):542–7.
Article
PubMed
Google Scholar
Lim Z, Downs J, Wong K, Ellaway C, Leonard H. Expanding the clinical picture of theMECP2Duplication syndrome. Clin Genet. 2017;91(4):557–63.
Article
CAS
PubMed
Google Scholar
Glaze DG, Percy AK, Skinner S, Motil KJ, Neul JL, Barrish JO, et al. Epilepsy and the natural history of Rett syndrome. Neurology. 2010;74:909–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tarquinio DC, Hou W, Berg A, Kaufmann WE, Lane JB, Skinner SA, et al. Longitudinal course of epilepsy in Rett syndrome and related disorders. Brain. 2017;140(2):306–18.
Article
PubMed
Google Scholar
Nissenkorn A, Gak E, Vecsler M, Reznik H, Menascu S, Ben ZB. Epilepsy in Rett syndrome–-the experience of a National Rett Center. Epilepsia. 2010;51(7):1252–8.
Article
PubMed
Google Scholar
Bao X, Downs J, Wong K, Williams S, Leonard H. Using a large international sample to investigate epilepsy in Rett syndrome. Dev Med Child Neurol. 2013;55(6):553–8.
Article
PubMed
Google Scholar
Abdala AP, Lioy DT, Garg SK, Knopp SJ, Paton JF, Bissonnette JM. Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome. Am J Respir Cell Mol Biol. 2014;50:1031-9.
Article
PubMed
PubMed Central
Google Scholar
Mackay J, Downs J, Wong K, Heyworth J, Epstein A, Leonard H. Autonomic breathing abnormalities in Rett syndrome: caregiver perspectives in an international database study. J Neurodev Disorders. 2017;9(1).
Tarquinio DC, Hou W, Neul JL, Berkmen GK, Drummond J, Aronoff E, et al. The course of awake breathing disturbances across the lifespan in Rett syndrome. Brain Develop. 2018;40(7):515–29.
Article
Google Scholar
[Available from: https://www.newron.com/news-and-media/regulatory-news/newron-reports-top-line-results-its-stars-study-evaluating-sarizotan.
Surtees ADR, Oliver C, Jones CA, Evans DL, Richards C. Sleep duration and sleep quality in people with and without intellectual disability: a meta-analysis. Sleep Med Rev. 2018;40:135–50.
Article
PubMed
Google Scholar
Hagberg B, Goutieres F, Hanefield F, Rett A, Wilson J. Rett syndrome: criteria for inclusion and exclusion. Brain Develop. 1985;7(3):372–3.
Article
CAS
Google Scholar
The Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol. 1988;23(4):425–8.
Article
Google Scholar
Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010;68(6):944–50.
Article
PubMed
PubMed Central
Google Scholar
Ellaway C, Peat J, Leonard H, Christodoulou J. Sleep dysfunction in Rett syndrome: lack of age related decrease in sleep duration. Brain Develop. 2001;23(Suppl 1):S101–3.
Article
Google Scholar
Wong K, Leonard H, Jacoby P, Ellaway C, Downs J. The trajectories of sleep disturbances in Rett syndrome. J Sleep Res. 2015;24(2):223–33.
Article
PubMed
Google Scholar
Boban S, Leonard H, Wong K, Wilson A, Downs J. Sleep Disturbances in Rett syndrome: impact and management including use of sleep hygiene practices. Am J Med Genet A. 2018;176(7):1569–77.
Article
PubMed
Google Scholar
Mori Y, Downs J, Wong K, Leonard H. Longitudinal effects of caregiving on parental well-being: the example of Rett syndrome, a severe neurological disorder. Eur Child Adolesc Psychiatry. 2018.
Mori Y, Downs J, Wong K, Heyworth J, Leonard H. Comparing parental well-being and its determinants across three different genetic disorders causing intellectual disability. J Autism Dev Disord. 2017;48(5):1651–65.
Article
Google Scholar
Boban S, Wong K, Epstein A, Anderson B, Murphy N, Downs J, et al. Determinants of sleep disturbances in Rett syndrome: Novel findings in relation to genotype. Am J Med Genet A. 2016;170(9):2292–300.
Article
CAS
PubMed
Google Scholar
Downs J, Torode I, Wong K, Ellaway C, Elliott EJ, Izatt MT, et al. Surgical fusion of early onset severe scoliosis increases survival in Rett syndrome: a cohort study. Dev Med Child Neurol. 2016;58(6):632–8.
Article
PubMed
Google Scholar
Downs J, Bergman A, Carter P, Anderson A, Palmer GM, Roye D, et al. Guidelines for management of scoliosis in Rett syndrome patients based on expert consensus and clinical evidence. Spine. 2009;34(17):E607–17.
Article
PubMed
Google Scholar
Jefferson A, Leonard H, Siafarikas A, Woodhead H, Fyfe S, Ward LM, et al. Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence. PLoS ONE. 2016;11(2):e0146824.
Article
PubMed
PubMed Central
Google Scholar
Ezeonwuka CD, Rastegar M. MeCP2-related diseases and animal models. Diseases. 2014;2(1):45–70.
Article
CAS
PubMed
Google Scholar
Zhang X, Lin J-S, Spruyt K. Sleep problems in Rett syndrome animal models: a systematic review. J Neurosci Res. 2021;99(2):529–44.
Article
CAS
PubMed
Google Scholar
Vashi N, Justice MJ. Treating Rett syndrome: from mouse models to human therapies. Mamm Genome. 2019;30(5–6):90–110.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sabitha KR, Shetty AK, Upadhya D. Patient-derived iPSC modeling of rare neurodevelopmental disorders: molecular pathophysiology and prospective therapies. Neurosci Biobehav Rev. 2020;121:201–19.
Article
PubMed
PubMed Central
Google Scholar
Roux JC, Zala D, Panayotis N, Borges-Correia A, Saudou F, Villard L. Unexpected link between Huntington disease and Rett syndrome. Med Sci (Paris). 2012;28(1):44–6.
Article
Google Scholar
Mancini J, Dubus JC, Jouve E, Roux JC, Franco P, Lagrue E, et al. Effect of desipramine on patients with breathing disorders in RETT syndrome. Ann Clin Transl Neurol. 2018;5(2):118–27.
Article
CAS
PubMed
Google Scholar
Smith-Hicks CL, Gupta S, Ewen JB, Hong M, Kratz L, Kelley R, et al. Randomized open-label trial of dextromethorphan in Rett syndrome. Neurology. 2017;89(16):1684–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li W, Pozzo-Miller L. BDNF deregulation in Rett syndrome. Neuropharmacology. 2014;76(Pt C):737–46.
Article
CAS
PubMed
Google Scholar
Deogracias R, Yazdani M, Dekkers MPJ, Guy J, Ionescu MCS, Vogt KE, et al. Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad Sci. 2012;109(35):14230–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Naegelin Y, Kuhle J, Schädelin S, Datta AN, Magon S, Amann M, et al. Fingolimod in children with Rett syndrome: the FINGORETT study. Orphanet J Rare Dis. 2021;16(1):19.
Article
PubMed
PubMed Central
Google Scholar
Khwaja OS, Ho E, Barnes KV, O’Leary HM, Pereira LM, Finkelstein Y, et al. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci USA. 2014;111(12):4596–601.
Article
CAS
PubMed
PubMed Central
Google Scholar
O’Leary HM, Kaufmann WE, Barnes KV, Rakesh K, Kapur K, Tarquinio DC, et al. Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol. 2018;5(3):323–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Glaze DG, Neul JL, Percy A, Feyma T, Beisang A, Yaroshinsky A, et al. A Double-Blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of Rett syndrome. Pediatr Neurol. 2017;76:37–46.
Article
PubMed
Google Scholar
Glaze DG, Neul JL, Kaufmann WE, Berry-Kravis E, Condon S, Stoms G, et al. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. Neurology. 2019;92(16):e1912–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaufmann WE, Sprouse J, Rebowe N, Hanania T, Klamer D, Missling CU. ANAVEX(R)2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. Pharmacol Biochem Behav. 2019;187:172796.
Article
CAS
PubMed
Google Scholar
Al-Zaidy SA, Mendell JR. From clinical trials to clinical practice: practical considerations for gene replacement therapy in SMA type 1. Pediatr Neurol. 2019;100:3–11.
Article
PubMed
Google Scholar
Sandweiss AJ, Brandt VL, Zoghbi HY. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies. Lancet Neurol. 2020;19(8):689–98.
Article
CAS
PubMed
Google Scholar
Hordeaux J, Buza EL, Dyer C, Goode T, Mitchell TW, Richman L, et al. Adeno-associated virus-induced dorsal root ganglion pathology. Hum Gene Ther. 2020;31(15–16):808–18.
Article
CAS
PubMed
Google Scholar
Hordeaux J, Buza EL, Jeffrey B, Song C, Jahan T, Yuan Y, et al. MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates. Sci Transl Med. 2020;12(569).
Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet. 2004;13(21):2679–89.
Article
CAS
PubMed
Google Scholar
Van Esch H. MECP2 duplication syndrome. Mol Syndromol. 2012;2(3–5):128–36.
PubMed
Google Scholar
Sinnett SE, Gray SJ. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome. Discov Med. 2017;24(132):153–9.
PubMed
Google Scholar
Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.
Article
CAS
PubMed
Google Scholar
Thompson R, Robertson A, Lochmuller H. Natural history, trial readiness and gene discovery: advances in patient registries for neuromuscular disease. Adv Exp Med Biol. 2017;1031:97–124.
Article
PubMed
Google Scholar
Wood L, Bassez G, Bleyenheuft C, Campbell C, Cossette L, Jimenez-Moreno AC, et al. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease. Orphanet J Rare Dis. 2018;13(1):155.
Article
PubMed
PubMed Central
Google Scholar
Straub V, Bertoli M. Where do we stand in trial readiness for autosomal recessive limb girdle muscular dystrophies? Neuromuscul Disord. 2016;26(2):111–25.
Article
PubMed
Google Scholar
Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, et al. Best practices in fragile X syndrome treatment development. Brain Sci. 2018;8(12).
Grillo E, Villard L, Clarke A, Ben Zeev B, Pineda M, Bahi-Buisson N, et al. Rett Networked Database: an integrated clinical and genetic network of Rett syndrome databases. Hum Mutat. 2012.
Bai D, Hon Kei Yip B, Windham GC, Sourander A, Francis R, Yoffe R, et al. Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry. 2019;76(10):1035–43.
Article
PubMed
PubMed Central
Google Scholar
Downs J, Torode I, Wong K, Ellaway C, Elliott EJ, Christodoulou J, et al. The natural history of scoliosis in females with Rett syndrome. Spine Phila (Pa 1976). 2016;41(10):856–63.
Article
Google Scholar
Downs J, Rodger J, Li C, Tan X, Hu N, Wong K, et al. Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial. Orphanet J Rare Dis. 2018;13(3):1–9.
Google Scholar
Jacoby P, Epstein A, Kim R, Murphy N, Leonard H, Williams K, et al. Reliability of the quality of life inventory-disability measure in children with intellectual disability. J Dev Behav Pediatr. 2020;41(7):534–9.
Article
PubMed
Google Scholar
Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17(4):280–99.
Article
CAS
PubMed
Google Scholar
Boxer AL, Gold M, Feldman H, Boeve BF, Dickinson SL, Fillit H, et al. New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures. Alzheimers Dement. 2020;16(1):131–43.
Article
PubMed
PubMed Central
Google Scholar
Mendoza J, Downs J, Wong K, Leonard H. Determinants of quality of life in Rett syndrome: new findings on associations with genotype. J Med Genet. 2020.
Townend GS, Bartolotta TE, Urbanowicz A, Wandin H, Curfs LMG. Development of consensus-based guidelines for managing communication of individuals with Rett syndrome. Augment Altern Commun. 2020;36(2):71–81.
Article
PubMed
Google Scholar
Mingorance A, Jaksha A, Smart T, Sherriff L, Valentine J. The Voice of the Patient Report: CDKL5 Deficiency Disorder (CDD): Lou Lou Foundation, International Foundation for CDKL5 Research; 2020 [Available from: https://www.cdkl5.com/wp-content/uploads/2020/06/CDD-VoP-REPORT.pdf.
Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18(9):1263–78.
Article
PubMed
Google Scholar
US Department of Health and Human Services Food & Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, MD: Food and Drug Administration, U.S. Department of Health and Human Services; 2009.
Saby JN, Peters SU, Roberts TPL, Nelson CA, Marsh ED. Evoked potentials and EEG analysis in Rett syndrome and related developmental encephalopathies: towards a biomarker for translational research. Front Integr Neurosci. 2020;14:30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Foxe JJ, Burke KM, Andrade GN, Djukic A, Frey HP, Molholm S. Automatic cortical representation of auditory pitch changes in Rett syndrome. J Neurodev Disord. 2016;8(1):34.
Article
PubMed
PubMed Central
Google Scholar
Goffin D, Allen M, Zhang L, Amorim M, Wang IT, Reyes AR, et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci. 2011;15(2):274–83.
Article
PubMed
PubMed Central
Google Scholar
Artoni P, Piffer A, Vinci V, LeBlanc J, Nelson CA, Hensch TK, et al. Deep learning of spontaneous arousal fluctuations detects early cholinergic defects across neurodevelopmental mouse models and patients. Proc Natl Acad Sci USA. 2020;117(38):23298–303.
Article
CAS
PubMed
Google Scholar
LeBlanc JJ, DeGregorio G, Centofante E, Vogel-Farley VK, Barnes K, Kaufmann WE, et al. Visual evoked potentials detect cortical processing deficits in Rett syndrome. Ann Neurol. 2015;78(5):775–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Orefice LL, Zimmerman AL, Chirila AM, Sleboda SJ, Head JP, Ginty DD. Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs. Cell. 2016;166(2):299–313.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saby JN, Benke TA, Peters SU, Standridge SM, Matsuzaki J, Cutri-French C, et al. multisite study of evoked potentials in rett syndrome. Ann Neurol. 2021;89(4):790–802.
Article
CAS
PubMed
Google Scholar
Saravanapandian V, Frohlich J, Hipp JF, Hyde C, Scheffler AW, Golshani P, et al. Properties of beta oscillations in Dup15q syndrome. J Neurodev Disord. 2020;12(1):22.
Article
PubMed
PubMed Central
Google Scholar
Frohlich J, Senturk D, Saravanapandian V, Golshani P, Reiter LT, Sankar R, et al. A Quantitative electrophysiological biomarker of duplication 15q11.2-q13.1 syndrome. PLoS ONE. 2016;11(12):e0167179.
Article
PubMed
PubMed Central
Google Scholar
Ostrowski LM, Spencer ER, Bird LM, Thibert R, Komorowski RW, Kramer MA, et al. Delta power robustly predicts cognitive function in Angelman syndrome. Ann Clin Transl Neurol. 2021;8:1433–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Raspa M, Bann CM, Gwaltney A, Benke TA, Fu C, Glaze DG, et al. A psychometric evaluation of the motor-behavioral assessment scale for use as an outcome measure in rett syndrome clinical trials. Am J Intellect Dev Disabil. 2020;125(6):493–509.
Article
PubMed
PubMed Central
Google Scholar
Neul JL, Glaze DG, Percy AK, Feyma T, Beisang A, Dinh T, et al. Improving treatment trial outcomes for rett syndrome: the development of rett-specific anchors for the clinical global impression scale. J Child Neurol. 2015;30(13):1743–8.
Article
PubMed
PubMed Central
Google Scholar
Mount RH, Charman T, Hastings RP, Reilly S, Cass H. The Rett Syndrome Behaviour Questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome. J Child Psychol Psychiatry. 2002;43(8):1099–110.
Article
PubMed
Google Scholar
Robertson L, Hall S, Jacoby P, Ellaway C, de Klerk N, Leonard H. The association between behaviour and genotype in Rett Syndrome using the Australian Rett syndrome database. Am J Med Genet B Neuropsychiatr Genet. 2006;141(2):177–83.
Article
Google Scholar
Hou W, Bhattacharya U, Pradana WA, Tarquinio DC. Assessment of a clinical trial metric for rett syndrome: critical analysis of the Rett Syndrome Behavioural Questionnaire. Pediatr Neurol. 2020;107:48–56.
Article
PubMed
Google Scholar
Oberman LM, Downs J, Cianfaglione R, Leonard H, Kaufmann WE. Assessment of a clinical trial metric for rett syndrome: critical analysis of the Rett Syndrome behaviour questionnaire. Pediatr Neurol. 2020;111:4.
Article
PubMed
Google Scholar
Barnes KV, Coughlin FR, O’Leary HM, Bruck N, Bazin GA, Beinecke EB, et al. Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales. J Neurodev Disord. 2015;7(1):30.
Article
PubMed
PubMed Central
Google Scholar
Downs J, Stahlhut M, Wong K, Syhler B, Bisgaard AM, Jacoby P, et al. Validating the Rett syndrome gross motor scale. PLoS ONE. 2016;11(1):e0147555.
Article
PubMed
PubMed Central
Google Scholar
Lotan M, Schenker R, Wine J, Downs J. The conductive environment enhances gross motor function of girls with Rett syndrome. A pilot study. Dev Neurorehabil. 2012;15(1):19–25.
Article
PubMed
Google Scholar
Downs J, Bebbington A, Jacoby P, Williams AM, Ghosh S, Kaufmann WE, et al. Level of purposeful hand function as a marker of clinical severity in Rett syndrome. Dev Med Child Neurol. 2010;52(9):817–23.
Article
PubMed
PubMed Central
Google Scholar
Clarkson T, Leblanc J, Degregorio G, Vogel-Farley V, Barnes K, Kaufmann WE, et al. Adapting the Mullen scales of early learning for a standardized measure of development in children with Rett Syndrome. Intellect Dev Disabil. 2017;55(6):419–31.
Article
PubMed
Google Scholar
Wetherby AM. Validity and reliability of the communication and symbolic bebavior scales developmental profile witb very young cbiidren. J Speech Hear Res. 2002;45:1202–18.
Article
Google Scholar
Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. J Autism Dev Disord. 2003;33(6):617–29.
Article
PubMed
Google Scholar
Ji NY, Capone GT, Kaufmann WE. Autism spectrum disorder in Down syndrome: cluster analysis of Aberrant Behaviour Checklist data supports diagnosis. J Intellect Disabil Res. 2011;55(11):1064–77.
Article
CAS
PubMed
Google Scholar
Berg AT, Gaebler-Spira D, Wilkening G, Zelko F, Knupp K, Dixon-Salazar T, et al. Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: a functional framework. Epilepsy Behav. 2020;111:107.
Article
Google Scholar
Downs J, Jacoby P, Leonard H, Epstein A, Murphy N, Davis E, et al. Psychometric properties of the quality of life inventory-disability (QI-Disability) measure. Qual Life Res. 2019;28:783–94.
Article
PubMed
Google Scholar
Lane JB, Lee HS, Smith LW, Cheng P, Percy AK, Glaze DG, et al. Clinical severity and quality of life in children and adolescents with Rett syndrome. Neurology. 2011;77(20):1812–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Epstein A, Williams K, Reddihough D, Murphy N, Leonard H, Whitehouse A, et al. Content validation of the Quality of Life Inventory – Disability (QI-Disability). Child Care Health Dev. 2019;45:654–9.
Article
PubMed
Google Scholar
Carroll MS, Ramirez JM, Weese-Mayer DE. Diurnal variation in autonomic regulation among patients with genotyped Rett syndrome. J Med Genet. 2020;57(11):786–93.
Article
CAS
PubMed
Google Scholar
Müller AR, Brands MMMG, van de Ven PM, Roes KCB, Cornel MC, van Karnebeek CDM, et al. Systematic review of N-of-1 studies in rare genetic neurodevelopmental disorders the power of 1. Neurology. 2021;96(11):529–40.
Article
PubMed
PubMed Central
Google Scholar
Sahin M, Jones SR, Sweeney JA, Berry-Kravis E, Connors BW, Ewen JB, et al. Discovering translational biomarkers in neurodevelopmental disorders. Nat Rev Drug Discov. 2018;18:235–6.
Google Scholar
Sanders SJ, Sahin M, Hostyk J, Thurm A, Jacquemont S, Avillach P, et al. A framework for the investigation of rare genetic disorders in neuropsychiatry. Nat Med. 2019;25(10):1477–87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Díaz-Caneja CM, State MW, Hagerman RJ, Jacquemont S, Marín O, Bagni C, et al. A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders. Eur Neuropsychopharmacol. 2021.
Bhatt DL, Mehta C. Adaptive designs for clinical trials. N Engl J Med. 2016;375(1):65–74.
Article
PubMed
Google Scholar